S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
Comprehensive Analysis of PayPal Stock
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
Comprehensive Analysis of PayPal Stock
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
Comprehensive Analysis of PayPal Stock
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
Comprehensive Analysis of PayPal Stock
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19

Coeptis Therapeutics (COEP) Earnings Date, Estimates & Call Transcripts

$0.33
-0.02 (-5.70%)
(As of 04/19/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 20Estimated
Actual EPS
(Mar. 25)
-$0.08 Missed By -$0.08
Skip Charts & View Estimated and Actual Earnings Data

COEP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

COEP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Coeptis Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.77) EPS

COEP Earnings Date and Information

Coeptis Therapeutics last announced its earnings results on March 25th, 2024. The reported ($0.08) EPS for the quarter. Coeptis Therapeutics has generated ($0.84) earnings per share over the last year (($0.84) diluted earnings per share). Coeptis Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

Coeptis Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/20/2024
Estimated)
------- 
3/25/2024Q4 2023-($0.08)($0.08)($0.08)--
11/9/2023Q3 2023-($0.29)($0.29)($0.35)--
8/28/2023Q2 2023-($0.14)($0.14)($0.14)--
5/15/2023Q1 2023-($0.39)($0.39)($0.39)--

Coeptis Therapeutics Earnings - Frequently Asked Questions

When is Coeptis Therapeutics's earnings date?

Coeptis Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on COEP's earnings history.

How much revenue does Coeptis Therapeutics generate each year?

Coeptis Therapeutics (NASDAQ:COEP) has a recorded annual revenue of $80,000.00.

How much profit does Coeptis Therapeutics generate each year?

Coeptis Therapeutics (NASDAQ:COEP) has a recorded net income of -$21.27 million. COEP has generated -$0.84 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NASDAQ:COEP) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners